Missing Information
  • A System Error Has Occured:0018 - Company Information Failed to Load.
Company:  MOMENTA PHARMACEUTICALS I ... (MNTA)
CIK:  0001235010 
Address:  301 BINNEY STREET 
City, State, Zip:  CAMBRIDGE,  02142 
Telephone:  617 491-9700 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$13.38  
Change: 
0.06 (0.45%)  
Trade Time: 
Sep 20  
Market Cap: 
$1.32B
Trade MNTA now with

© 2019  
Description of Business
We are a biotechnology company focused on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Our goal is to develop molecules that drive significant advances in the control over or cure of immune-driven disease. To do this, we draw on our strong analytic heritage to interrogate immune biology to identify and validate high-priority targets. We then use our protein design expertise to refine the structure of our biological product candidates to optimize their potency and pharmacokinetics, while minimizing potential toxicities. Our initial focus in immune biology has been to explore the interaction between antibodies, which are components of the humoral immune system, and the receptors which bind to the fragment crystallizable (Fc) region of antibodies and modulate the immune cascade. Our objective is to reduce immune driven tissue damage resulting from autoimmune disease.
Register and access this filing in:     
  FORM S-3ASR
    CALCULATION OF REGISTRATION FEE
    THE OFFERING
    EXPLANATORY NOTE
    Offered by the Selling Securityholders
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS
    WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY REFERENCE
    RISK FACTORS
    USE OF PROCEEDS
    DESCRIPTION OF CAPITAL STOCK
    DESCRIPTION OF DEBT SECURITIES
    DESCRIPTION OF WARRANTS
    SELLING SECURITYHOLDERS
    PLAN OF DISTRIBUTION
    LEGAL MATTERS
    EXPERTS
    RISK FACTORS
    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    DILUTION
    MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S ...
    PART II
      Item 14. Other Expenses of Issuance and Distribution
      Item 15. Indemnification of Directors and Officers
      Item 16. Exhibits
      Item 17. Undertakings
    SIGNATURES
    POWER OF ATTORNEY
    EXHIBIT INDEX
  EXHIBIT 1.2
  EXHIBIT 4.2
  EXHIBIT 5.1
  EXHIBIT 23.2
    Consent of Independent Registered Public Accounting Firm
  EXHIBIT 25.1